2018
DOI: 10.1016/j.biopha.2017.10.066
|View full text |Cite
|
Sign up to set email alerts
|

Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
45
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(46 citation statements)
references
References 20 publications
1
45
0
Order By: Relevance
“…In this research, we unveiled that lncRNA CASC11 and CDK1 were overexpressed in gastric carcinoma tissues and cells, while miR-340-5p was lowly expressed in GC. In previous studies, Quan-Hong Qin et al verified that lncRNA 01296 plays an oncogenic lncRNA role in GC carcinogenesis, suggesting a regulatory pathway of lncRNA 01296/miR-122/ MMP-9 in GC tumorigenesis [29]. Jie Liu et al revealed that overexpression of lncRNA SNHG20 in gastric tumor cells significantly inhibits the expression of E-cadherin and p21 by binding to Figure 7.…”
Section: Discussionmentioning
confidence: 96%
“…In this research, we unveiled that lncRNA CASC11 and CDK1 were overexpressed in gastric carcinoma tissues and cells, while miR-340-5p was lowly expressed in GC. In previous studies, Quan-Hong Qin et al verified that lncRNA 01296 plays an oncogenic lncRNA role in GC carcinogenesis, suggesting a regulatory pathway of lncRNA 01296/miR-122/ MMP-9 in GC tumorigenesis [29]. Jie Liu et al revealed that overexpression of lncRNA SNHG20 in gastric tumor cells significantly inhibits the expression of E-cadherin and p21 by binding to Figure 7.…”
Section: Discussionmentioning
confidence: 96%
“…Zhang et al reported that LINC01296 aggravates cholangiocarcinoma cell growth and progression by sponging miR‐5095 . In gastric cancer, LINC01296 facilitates cell progression via the miR‐122/matrix metalloprotein‐9 (MMP‐9) pathway . Moreover, several publications also found that LINC01296 could predict poor prognosis for some malignancies, including prostate cancer and colorectal cancer .…”
Section: Introductionmentioning
confidence: 99%
“…A total of nine eligible studies21–25 28 31–33 (one gastric cancer, one oesophageal cancer, one prostate cancer, one cholangiocarcinoma, one colon cancer, one breast cancer, one pancreatic ductal adenocarcinoma, one bladder cancer and one hepatocellular carcinoma) were enrolled in this meta-analysis. The basic information and characteristics of each trial were summarised in tables 1–3.…”
Section: Resultsmentioning
confidence: 99%
“…In this meta-analysis, the expression level of LINC01296 was examined by qRT-PCR in all studies. The median expression of LINC01296 in Qin’s,22 Wang’s28 and Wan’s33 articles was regarded as the cut-off value, while the mean expression was set as the cut-off value in Zhang’s,23 Yuan’s25 and Wang’s32 researches. However, other eligible articles did not report the cut-off value.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation